Demo
Close Language Tab
Locate us
Languages
M
Metropolis Healthcare Ltd Healthcare
₹ 1,962.80 +18.00 (0.93%)
  • NSE
  • BSE

Overview

  • BSE Code 542650
  • NSE Symbol METROPOLIS
  • ISIN Demat INE112L01020
  • Book Value (₹) 238.61
  • Face Value (₹) 2.00
  • Market Cap (₹ Cr.) 9,901.11
  • P/E (TTM) 76.70
  • EPS (TTM) 24.91
  • Div Yield (%) 0.00

Performance

Today’s Low 1,925.10
Today’s High 1,971.50

1,962.80
52W Low 1,315.00
52W High 2,263.00

1,962.80
Open 1,944.10
Prev. Close 1,944.80
Volume 40,201.00

Corporate Actions

Metropolis Healthcare Limited - Trading Window
Sep 30, 2025

Metropolis Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Metropolis Healthcare Limited - Updates
Apr 18, 2025

Metropolis Healthcare Limited has informed the Exchange regarding 'Allotment of 1,836 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020'.

Metropolis Healthcare Limited - Alteration Of Capital and Fund Raising-XBRL
Apr 18, 2025

METROPOLIS HEALTHCARE LIMITED has informed the Exchange regarding Allotment of Securities

About Metropolis Healthcare Ltd

Metropolis Healthcare Limited is one of the leading diagnostics companies in India. It owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. The Chairman, Dr Sushil Shah, founded the company in 1981 and established the first referral laboratory. In 1992, It started clinical research services. The company continued its organic growth and finished its first major acquisition of Sudharma in Kerala in 2001. During the same year, the company started the home service vertical. _x000D_ _x000D_ In 2013, it expanded the services of Metropolis to developing African countries. After three years, the company inducted the new professional management team and rolled out Metropolis's retail strategy in 2016. The company was listed on the Indian stock exchanges successfully in 2019 after an IPO to the public. In 2023, it launched Metropolis 3.0 strategy to broaden its consumer reach via the Direct to Consumer (D2C) model with a focus on building chronic and wellness businesses._x000D_

Business Segments

_x000D_
    _x000D_
  • Pathology Testing Services: Under this segment, the company provides services such as Blood Tests, Diagnostics and Wellness services. It has operations across India, Africa, South Asia, and the Middle East.
  • _x000D_
  • Corporate Wellness: Under this segment, it ties up with organisations and provides pre-employment check-ups, employee health plans, and annual check-ups for corporates to build a healthy workforce. 
  • _x000D_
  • Lab in Hospitals: The company partners with hospitals to provide diagnostics services. Currently, it is a partnership with many hospitals across geographies and offers full-scale in-house pathology services and solutions.
  • _x000D_
  • Clinical Research Services: It offers analytical and support services such as logistics and EDI to contract research organisations for their clinical research projects.
  • _x000D_
_x000D_ Subsidiaries_x000D_ _x000D_ As of March 31, 2023, the company had 11 subsidiaries and a few of them are listed below:_x000D_
    _x000D_
  • Amin's Pathology Laboratory Private Limited: It is a wholly-owned subsidiary which provides over 50 different types of medical with the latest and the best automated equipment.
  • _x000D_
  • Centralab Healthcare Services Private Limited: This is a wholly owned subsidiary which is engaged in providing healthcare services to customers.
  • _x000D_
_x000D_

Key Personnel:

_x000D_ Dr Sushil Shah, Chairman and Executive Director_x000D_ _x000D_ Dr. Sushil Shah is the Founder and Chairman of the company. He completed his M.B.B.S. in 1972 and M.D. in Pathology and Bacteriology from Grant Medical College in 1975. In 1978, he received a Research Fellowship in Endocrine Pathology at the esteemed Cornell Medical Centre._x000D_ _x000D_ Ms Ameera Shah,  Promoter and Managing Director _x000D_ _x000D_ Ms Ameera Shah is the Promoter and Managing Director of the company. She is a global thought leader in the healthcare industry and played an instrumental role in changing the pathology industry landscape in the country. _x000D_

Corporate Action

_x000D_ The company has no history of bonus issues, stock splits and other corporate actions.
Founded: 2000
Chairman: Ameera Sushil Shah
Managing Director: Surendran Chemmenkotil
Address: 250 D Udyog Bhavan, Worli, Mumbai, Maharashtra, 400030,

Frequently Asked Questions

What is the price of Metropolis Healthcare Ltd share today? +
How to buy stock of Metropolis Healthcare Ltd? +
What is the 52 Week High and Low of Metropolis Healthcare Ltd? +
What is the PE ratio of Metropolis Healthcare Ltd? +
What is the Market Cap of Metropolis Healthcare Ltd? +